SCHEMBL875661

SCHEMBL875661

ONc1ccccc1COc1cc[nH]n1

nearest known ligand 0.30

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
▸ CNR1 P21554 1/20 0.30
▸ CNR2 P34972 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1461334 0.76 IDO1 (0.47) —
SCHEMBL28863349 0.72 IDO1 (0.51) —
SCHEMBL15096092 0.72 KDM1A (0.36) —
SCHEMBL1386973 0.71 GABRP (0.44) —
SCHEMBL10099044 0.70 CYP2C9 (0.39) —
SCHEMBL1460167 0.70 KMT2A (0.49) —
Hydrochloric Acid SCHEMBL2581851 0.69 GABRG2 (0.43) —
SCHEMBL13943874 0.69 PTGDR2 (0.30) —
SCHEMBL28592347 0.69 KMT2A (0.38) —
SCHEMBL30817782 0.68 KMT2A (0.30) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2619183-B1 PROCESS FOR PREPARING SUBSTITUTED N-PHENYLHYDROXYLAMINES BASF SE (DE) 2016-12-07 — — EP disclosed
US-8563748-B2 Process for preparing substituted N-phenylhydroxylamines BASF SE (DE) 2013-10-22 — — US disclosed
EP-2619183-A1 PROCESS FOR PREPARING SUBSTITUTED N-PHENYLHYDROXYLAMINES BASF SE (DE) 2013-07-31 — — EP disclosed
US-20130178634-A1 Process for Preparing Substituted N-Phenylhydroxylamines BASF SE (DE) 2013-07-11 — — US disclosed
WO-2012038392-A1 PROCESS FOR PREPARING SUBSTITUTED N-PHENYLHYDROXYLAMINES BASF SE (DE) 2012-03-29 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130178634-A1 Process for Preparing Substituted N-Phenylhydroxylamines PAH, HPD, DNPH1 CNR1 1338/4885CNR2 1125/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback